The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.

US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable.

The Chinese Ministry for Commerce said the “EU has insisted on taking restrictive measures to build new protectionist barriers”.

USW researchers are set to develop biodegradable batteries that can be positioned in humans for powering medical implants.

Welsh startup Amotio has raised £810,000 ($1.1m) to advance its technology for improving outcomes during orthopaedic revision surgery.

A Karolinska Institutet-led study has demonstrated that the use of an AI tool can enhance skin cancer diagnosis.

Intuitive’s multiport robotic-assisted surgical system, da Vinci 5, has secured the CE mark approval for use in adult and paediatric patients.

Cognito Therapeutics has reached its enrolment goal for the HOPE Study investigating the Spectris AD system for Alzheimer's disease (AD).

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Philips’ SmartSpeed Precise deep learning reconstruction software.

InterShunt has initiated the EASE HF2 early feasibility study of the InterShunt percutaneous atrial shunt catheter (PAS-C) system.

Fresenius Medical Care (FME) has collaborated with Mexico's CCINSHAE to extend HighVolumeHDF access to individuals.

Kardium has raised C$340m ($250m) to support the launch of its Globe pulsed field (PF) System for treating atrial fibrillation (AFib).